Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis

NCT04789915 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Psychosis
Negative Symptoms With Primary Psychotic Disorder

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

Bjorn H. Ebdrup

Collaborators

[object Object]
[object Object]